Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Maubec

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2016
Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapyA Servy, E Maubec, P E Sugier, et al.
The British Journal of Dermatology|November 25, 2015
Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinomaM Samimi, L Molet, M Fleury, et al.
British Journal of Cancer|May 4, 2016
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanomaC Le Tourneau, B Dreno, Y Kirova, et al.
The British Journal of Dermatology|August 25, 2015
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelinesJ E Mellerio, S J Robertson, C Bernardis, et al.
Annales De Dermatologie Et De Venereologie|January 21, 2015
[Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma]M-F Avril, P Bahadoran, O Cabaret, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life studyK Khelef, E Maubec, G Jeudy, et al.
The British Journal of Dermatology|July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study GroupC Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2021
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data<sup>☆</sup>Y Di Filippo, S Dalle, L Mortier, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohortM Kandel, C Allayous, S Dalle, et al.
Annales De Dermatologie Et De Venereologie|September 5, 2025
Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel)F Skowron, S Mouret, A Seigneurin, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 27, 2016
Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapyA Servy, E Maubec, P E Sugier, et al.
The British Journal of Dermatology|November 25, 2015
Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinomaM Samimi, L Molet, M Fleury, et al.
British Journal of Cancer|May 4, 2016
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanomaC Le Tourneau, B Dreno, Y Kirova, et al.
The British Journal of Dermatology|August 25, 2015
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelinesJ E Mellerio, S J Robertson, C Bernardis, et al.
Annales De Dermatologie Et De Venereologie|January 21, 2015
[Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma]M-F Avril, P Bahadoran, O Cabaret, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life studyK Khelef, E Maubec, G Jeudy, et al.
The British Journal of Dermatology|July 8, 2015
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study GroupC Hurabielle, S Ingen-Housz-Oro, N Ortonne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2021
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data<sup>☆</sup>Y Di Filippo, S Dalle, L Mortier, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohortM Kandel, C Allayous, S Dalle, et al.
Annales De Dermatologie Et De Venereologie|September 5, 2025
Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel)F Skowron, S Mouret, A Seigneurin, et al.
Pageof 6